Luis Gil Abinader, @abinader.bsky.social retweeted
A must read: Abolishing USAID Is Both Unconstitutional and Disastrous
foreignpolicy.com/2025/02/04…
@MMKavanagh @abinader
Luis Gil Abinader, @abinader.bsky.social retweeted
New on #USAID: First, in @ForeignPolicy our piece on illegality of abolishing USAID. To be clear-eyed: This is neither good policy nor legal under the most basic elements of U.S. law and the Constitution.
w @abinader
And you can also read our memo...
foreignpolicy.com/2025/02/04…
Luis Gil Abinader, @abinader.bsky.social retweeted
🛑Closing down USAID is illegal.
📜It's an independent agency with authorities legislated by Congress.
⚠️The president has no legal authority to abolish or move it under the State Department unilaterally
Strong analysis by @MMKavanagh & @abinader.
👇🏼
bit.ly/4i2jeAH
Luis Gil Abinader, @abinader.bsky.social retweeted
👉MPP’s Expert Advisory Group meet in Geneva to provide critical guidance on our work. This group of experts in regulatory, IP law, public health, R&D, and more play a vital role in helping expand access to essential medicines worldwide. 🌍💊#AccessToMedicines
Luis Gil Abinader, @abinader.bsky.social retweeted
Excited to be meeting our 2025 @GeorgetownLaw health law LL.M. with @oneillinstitute in person! Thanks also to our amazing alumni for giving back to our new students. #HoyaHealthLawya!
Luis Gil Abinader, @abinader.bsky.social retweeted
Mylan’s legal fees for patent litigation:
2012: $46,158,403
2013: $38,211,911
2014: $38,618,993
If you want to launch a generic or biosimilar, be prepared to sink tens of millions of $ into legal fees to cut through patent thickets.
Luis Gil Abinader, @abinader.bsky.social retweeted
Good @TheLancet piece on the Pharmaceutical Accountability Foundation’s @StichtingFTV legal case against @abbvie for its excessive pricing of Humira thelancet.com/action/showPdf…
Luis Gil Abinader, @abinader.bsky.social retweeted
In 2019, Kamala Harris proposed the use of march-in rights to bring down drug prices.
Luis Gil Abinader, @abinader.bsky.social retweeted
Students in my clinic—the Science, Health & Information Clinic @ColumbiaLaw—represented @EFF in this motion, as part of a long-running partnership to protect the public's right to access evidence & arguments in patent & other "tech law" cases.
Next stop: the Federal Circuit!
We’re appealing a court order to fight for greater transparency in patent disputes. eff.org/deeplinks/2024/06/ef…
Luis Gil Abinader, @abinader.bsky.social retweeted
📰The US is nearing an agreement to bankroll a late-stage trial of Moderna’s mRNA pandemic bird flu vaccine.
💉It would be good to understand what, if any, access provisions are included in this deal.
Important @FT story. Thanks for breaking it @mroliverbarnes.
ft.com/content/fad59eb1-2f34…
Luis Gil Abinader, @abinader.bsky.social retweeted
.@moderna_tx tried to extract a huge price for its #COVID-19 #vaccine from the South African government at the height of the pandemic, according to the local NGO @HealthJusticeIn, in revelations made public this week.
✍ @kerrycullinan11
healthpolicy-watch.news/mode…
Luis Gil Abinader, @abinader.bsky.social retweeted
Comments accepted until July 22! Make your voice heard!
This Post is from an account that no longer exists. Learn more
Luis Gil Abinader, @abinader.bsky.social retweeted
Today we join @HealthJusticeIn in report showing Moderna & Pfizer wielded unprecedented power in COVID-19 negotiations w South Africa. The SA govt tried to include transparency, supply commitment, etc to realize its obligations under SA and Intl law. Was blocked by monopoly power
Breaking:⏰📢
'Groundbreaking Access to Documents Show Pharma Giants Bullied SA in Covid-19 Vaccine Negotiations'
Records & Analysis “The Negotiations, One Sided-Part 2’’ with @Public_Citizen @oneillinstitute is publicly available at:
healthjusticeinitiative.org.…
@peoplesvaccine
Luis Gil Abinader, @abinader.bsky.social retweeted
Breaking:⏰📢
'Groundbreaking Access to Documents Show Pharma Giants Bullied SA in Covid-19 Vaccine Negotiations'
Records & Analysis “The Negotiations, One Sided-Part 2’’ with @Public_Citizen @oneillinstitute is publicly available at:
healthjusticeinitiative.org.…
@peoplesvaccine
Luis Gil Abinader, @abinader.bsky.social retweeted
Documents: New pandemic deal texts circulated ahead of Fridayʼs deadline pro.politico.eu/news/179589
Luis Gil Abinader, @abinader.bsky.social retweeted
1. One way pharma companies block competition and inflate the cost of medicines is by filing bogus patent listings.
Today @FTC challenged over 300 junk patent listings, including for blockbuster weight-loss & type 2 diabetes drugs Ozempic and Victoza.
ftc.gov/news-events/news/pre…
Luis Gil Abinader, @abinader.bsky.social retweeted
The top 20 pharma companies by 2023 revenue fiercepharma.com/pharma/top-…
Luis Gil Abinader, @abinader.bsky.social retweeted
Inside Health Policy talked to @mcuban about the distribution of generic versions of Xtandi, if CMS allows generic manufacturers to the federal government's 35 USC 202(c)(4) royalty free right in the patents for federal programs.
New: @mcuban tells @InHealthPolicy he could take on the role of distributing the drugs should CMS back drug-pricing advocates’ proposed march-in alternative to license entities to make generic versions of expensive drugs like Xtandi. 👇
Luis Gil Abinader, @abinader.bsky.social retweeted
New law and policy portal with library of laws launched by @WHO @oneillinstitute to advance implementation of the Global health and care workers compact who.int/news/item/04-04-2024…
Luis Gil Abinader, @abinader.bsky.social retweeted
WTO has failed. It took years. But now eminently clear that the WTO is not capable of responding during a pandemic, securing rapid sharing of technology & global production of medical countermeasures.
Knowledge sharing/IP issue must shift to @WHO.
theguardian.com/global-devel…
























